Literature DB >> 14975764

Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats.

Hiroyuki Kobori1, Akira Nishiyama.   

Abstract

We have recently reported that Dahl salt-sensitive rats (DS) on high salt diet (HS) have an inappropriate augmentation of intrarenal angiotensinogen. Recent studies also reported that the augmented superoxide anion formation plays important roles in this animal model of hypertension. This study was performed to address the hypothesis that an inappropriate augmentation of intrarenal angiotensinogen by HS is caused by the augmented reactive oxygen species. Male DS (200-220 g) were maintained on low salt diet LS (N = 7) or HS (N = 27) for 4 weeks. The HS group was subdivided into three subgroups to receive null (N = 12), superoxide dismutase mimetic, tempol (3 mmol/l, N = 8), or vasodilator, hydralazine (0.5 mmol/l, N = 7) in drinking water during the period. Systolic BP was significantly increased in the DS+HS group compared to the DS+LS group (184+/-7 mmHg vs. 107+/-5 at 4-week). Tempol or hydralazine treatment equivalently attenuated the hypertension (128+/-3 and 127+/-5 at 4-week, respectively). Urinary excretion of thiobarbituric acid reactive substances at 4-week was significantly increased in the DS+HS group compared to the DS+LS group (0.66+/-0.05 micromol/day vs. 0.14+/-0.01). Tempol treatment prevented this effect (0.24+/-0.04) but hydralazine treatment only partially prevented the effect (0.40+/-0.03). Kidney angiotensinogen levels, measured by Western blot analysis, were significantly increased in the DS+HS group compared to the DS+LS group (32+/-5 densitometric units vs. 21+/-1). Tempol (14+/-3) but not hydralazine (32+/-5) treatment prevented the intrarenal angiotensinogen augmentation. The evidence suggests that the enhanced intrarenal angiotensinogen in DS challenged with HS is associated with the augmented reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14975764      PMCID: PMC3290764          DOI: 10.1016/j.bbrc.2004.01.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.

Authors:  W Hayashida; Y Kihara; A Yasaka; K Inagaki; Y Iwanaga; S Sasayama
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system.

Authors:  J R Ingelfinger; W M Zuo; E A Fon; K E Ellison; V J Dzau
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats.

Authors:  Akira Nishiyama; Toshiki Fukui; Yoshihide Fujisawa; Matlubur Rahman; Run-Xia Tian; Shoji Kimura; Youichi Abe
Journal:  Hypertension       Date:  2001-01       Impact factor: 10.190

4.  Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

5.  Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.

Authors:  P K Chatterjee; S Cuzzocrea; P A Brown; K Zacharowski; K N Stewart; H Mota-Filipe; C Thiemermann
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

6.  Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla.

Authors:  J R Ingelfinger; R E Pratt; K Ellison; V J Dzau
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

7.  Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension.

Authors:  Akira Nishiyama; Hiroyuki Kobori; Toshiki Fukui; Guo-Xing Zhang; Li Yao; Matlubur Rahman; Hirofumi Hitomi; Hideyasu Kiyomoto; Takatomi Shokoji; Shoji Kimura; Masakazu Kohno; Youichi Abe
Journal:  Hypertension       Date:  2003-07-21       Impact factor: 10.190

8.  PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney.

Authors:  Y Terada; K Tomita; H Nonoguchi; F Marumo
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

9.  Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage.

Authors:  A Samuni; D Winkelsberg; A Pinson; S M Hahn; J B Mitchell; A Russo
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

10.  Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats.

Authors:  Toshio Nishikimi; Yosuke Mori; Naohiko Kobayashi; Kazuyoshi Tadokoro; Xin Wang; Kazumi Akimoto; Fumiki Yoshihara; Kenji Kangawa; Hiroaki Matsuoka
Journal:  Hypertension       Date:  2002-06       Impact factor: 10.190

View more
  43 in total

Review 1.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.

Authors:  Yoshio Konishi; Akira Nishiyama; Takashi Morikawa; Chizuko Kitabayashi; Mikiko Shibata; Masahiro Hamada; Masatsugu Kishida; Hirofumi Hitomi; Hideyasu Kiyomoto; Takenori Miyashita; Nozomu Mori; Maki Urushihara; Hiroyuki Kobori; Masahito Imanishi
Journal:  Hypertension       Date:  2011-06-13       Impact factor: 10.190

3.  Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure.

Authors:  Casey M Rebholz; Jing Chen; Qi Zhao; Ji-Chun Chen; Jianxin Li; Jie Cao; Luis Gabriel Navar; Lotuce Lee Hamm; Dongfeng Gu; Jiang He
Journal:  J Hypertens       Date:  2015-07       Impact factor: 4.844

4.  Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Minolfa C Prieto-Carrasquero; Akira Nishiyama; Tatsuya Shoji; Eric P Cohen; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

Review 5.  Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.

Authors:  Christopher S Wilcox
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

6.  Urinary Angiotensinogen as a Potential Biomarker of Intrarenal Renin-angiotensin System Activity in Chinese Patients with Chronic Kidney Disease.

Authors:  Z Xu; B Xu; C Xu
Journal:  West Indian Med J       Date:  2014-07-03       Impact factor: 0.171

7.  Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Int J Clin Med       Date:  2011-09-01

8.  Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney.

Authors:  Masumi Kamiyama; Kristina M Farragut; Michelle K Garner; L Gabriel Navar; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

9.  Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice.

Authors:  Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Maki Urushihara; Hiroyuki Kobori
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-03-02       Impact factor: 2.557

10.  Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Yuri Ozawa; Ryousuke Satou; Kayoko Miyata; Naoki Hase; Yuki Suzaki; Tatsuya Shoji
Journal:  Biochem Biophys Res Commun       Date:  2007-04-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.